OIG Investigates NuVasive’s Medicare, Medicaid Claims
This article was originally published in The Gray Sheet
Executive Summary
NuVasive revealed June 30 that it was recently subpoenaed by OIG as part of an investigation into potentially false or improper Medicare and Medicaid claims. The company’s stock price fell more than 12 percent July 31, the day after its second quarter earnings report.